Leuprolide Acetate Kit
Product Images NDC 0781-4003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 0781-4003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

→ Leuprolide 1

→ Leuprolide 10

→ Leuprolide 11

→ Leuprolide 12

→ Leuprolide 13

→ Leuprolide 14

→ Leuprolide 2

→ Leuprolide 3

→ Leuprolide 4

→ Leuprolide 5

→ Leuprolide 6

→ Leuprolide 7

→ Leuprolide 8

→ Leuprolide 9

FDA Label Image

Leuprolide 1

FDA Label Image

Leuprolide 10

FDA Label Image

Leuprolide 11

FDA Label Image

Leuprolide 12

FDA Label Image

Leuprolide 13

FDA Label Image

Leuprolide 14

Leuprolide Acetate Injection is a sterile solution for subcutaneous injection. Each 0.2 mL contains 1 mg of Leuprolide Acetate, with a pH range of 4.0 to 6.0. It also includes sodium chloride, benzyl alcohol, and water for injection. The usual dosage is a 0.2 mL (1 mg) subcutaneous injection once daily. It is manufactured by Oakwood Laboratories, L.L.C. in Ohio, USA, and distributed by Sandoz Inc. in New Jersey, USA. The drug should be stored below 25°C, protected from light and kept out of reach of children. For further information, refer to the package insert.*

FDA Label Image